Foa R - Search Results

1

Autocrine or paracrine models of cytokine production and utilization in B-cell chronic lymphocytic leukaemia.

Foa R, Giovarelli M, Fierro MT, Bonferroni M, Forni G. Foa R, et al. Nouv Rev Fr Hematol (1978). 1988;30(5-6):339-41. Nouv Rev Fr Hematol (1978). 1988. PMID: 3065732 Review.

2

Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization?

Giovarelli M, Foa R, Benetton G, Lusso P, Fierro MT, Forni G. Giovarelli M, et al. Among authors: foa r. Leuk Res. 1988;12(3):201-9. doi: 10.1016/0145-2126(88)90137-3. Leuk Res. 1988. PMID: 3259277

3

Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.

Foa R, Massaia M, Cardona S, Tos AG, Bianchi A, Attisano C, Guarini A, di Celle PF, Fierro MT. Foa R, et al. Blood. 1990 Jul 15;76(2):393-400. Blood. 1990. PMID: 2114936 Free article.

4

Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.

Foa R, Fierro MT, Raspadori D, Bonferroni M, Cardona S, Guarini A, Tos AG, di Celle PF, Cesano A, Matera L. Foa R, et al. Blood. 1990 Oct 1;76(7):1349-54. Blood. 1990. PMID: 2207312 Free article.

5

Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin.

Foa R, Caretto P, Fierro MT, Bonferroni M, Cardona S, Guarini A, Lista P, Pegoraro L, Mandelli F, Forni G, et al. Foa R, et al. Br J Haematol. 1990 May;75(1):34-40. doi: 10.1111/j.1365-2141.1990.tb02613.x. Br J Haematol. 1990. PMID: 2375921

6

Lymphokine activated killer (LAK) activity in lymphoproliferative disorders.

Foa R, Fierro MT, Raspadori D, Bonferroni M, Cardona S, Liao XS, Cesano A, Matera L, Gillio Tos A, Tola E, et al. Foa R, et al. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:153-5. Bone Marrow Transplant. 1989. PMID: 2653494 Review.

7

Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cells.

Lista P, Fierro MT, Liao XS, Bonferroni M, Brizzi MF, Porcu P, Pegoraro L, Foa R. Lista P, et al. Among authors: foa r. Eur J Haematol. 1989 May;42(5):425-30. doi: 10.1111/j.1600-0609.1989.tb01465.x. Eur J Haematol. 1989. PMID: 2786477

8

Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2).

Foa R, Fierro MT, Giovarelli M, Lusso P, Benetton G, Bonferroni M, Forni G. Foa R, et al. Blood Cells. 1987;12(2):399-412. Blood Cells. 1987. PMID: 2887225

9

Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population.

Foa R, Giovarelli M, Jemma C, Fierro MT, Lusso P, Ferrando ML, Lauria F, Forni G. Foa R, et al. Blood. 1985 Sep;66(3):614-9. Blood. 1985. PMID: 2992637 Free article.

10

In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity.

Fierro MT, Liao XS, Lusso P, Bonferroni M, Matera L, Cesano A, Lista P, Arione R, Forni G, Foa R. Fierro MT, et al. Among authors: foa r. Leukemia. 1988 Jan;2(1):50-4. Leukemia. 1988. PMID: 3257539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

937 results

Search Page

Filters